SEARCH

SEARCH BY CITATION

Keyword index

  1. Top of page
  2. Keyword index
  • acquired phytosterolaemia, 660
  • actin binding domain, 774
  • activated protein C, 197
  • activatory NK-cell receptors, 91
  • acute, 398
  • acute leukaemia, 740
  • acute lymphoblastic leukaemia, 452, 539
  • acute myeloid leukaemia, 91, 230, 398, 576, 755
  • acute  -12, 576
  • acute  -10, 576
  • acute promyelocytic leukaemia, 379
  • ADAMTS13, 66
  • adherence, 512
  • adverse events, 532
  • Affymetrix, 303
  • Akt, 503
  • alemtuzumab, 3
  • alkaloids, 615
  • allelic transcript, 494
  • allogeneic
  • allogeneic haematopoietic stem cell transplantation, 326
  • allogeneic transplant, 747
  • allogenic bone marrow transplantation, 594
  • AMD3100, 255
  • δ-aminolaevulinate dehydratase, 237
  • AML, 794, 795
  • amphotericin B, 658
  • anaemia, 608
  • anaplastic large cell lymphoma, 594
  • antibodies, 317
  • anticoagulants, 197
  • anticoagulation, 598
  • antigen stimulation, 571
  • apoptosis, 503, 560, 615, 698
  • asparagine synthetase, 740
  • aspergillosis, 138
  • Auer rods, 162
  • autoantibody, 487
  • autograft, 755
  • autoimmune
  • autoimmune cytopenias, 125
  • autoimmune disease, 66
  • autoimmune haemolytic anaemia, 125, 655
  • autoimmune thrombocytopenia, 125
  • autologous stem cell transplantation, 42, 594
  • azole, 658
  • bacitracin, 339
  • bacteraemia, 25
  • Bcl-2, 743
  • BCR/ABL, 774
  • BCR-ABL, 359
  • bias, 747
  • bisphosphonates, 114
  • blood
  • blood groups, 374
  • blood transfusion, 531
  • bone marrow
  • bone marrow bone marrow, 255
  • bone marrow failure, 630
  • bone marrow microenvironment, 385
  • bone marrow transplantation, 658, 755
  • β-thalassaemia, 640
  • calibration, 75
  • (CA)n microsatellite, 326
  • candidiasis, 138
  • cardiovascular genetics, 494
  • case–control studies, 798
  • caspases, 349, 560
  • CCL20, 293
  • CD27, 168
  • CD30, 503
  • CD40, 503
  • CD64, 317
  • CD44 variants, 469
  • CD4+ cytotoxic T cells, 56
  • CD34+ enrichment, 42
  • cell-cycle arrest, 615
  • central nervous system, 245
  • chemokine, 255
  • chemoresistance, 560
  • chemotherapy, 410, 552, 723
  • chimaerism, 36
  • Chlamydia psittaci, 651
  • chromosomes, 705
  • chronic
  • chronic idiopathic neutropenia, 637
  • chronic lymphocytic leukaemia, 705
  • chronic myeloid leukaemia, 32, 359, 736, 774
  • clinical
  • clinical aspects, 630
  • clinical trial, 747
  • clinical trials, 723, 794, 795
  • clonal, 286
  • coagulation cascade, 268
  • commutability, 75
  • comorbidity, 25
  • coproporphyrinogen oxidase, 237
  • cryptic exosites, 487
  • cutaneous B-cell lymphoma, 571
  • cytokines, 784
  • cytometric bead array, 32
  • cytostatics, 230
  • death factors, 560
  • deep-vein thrombosis, 333
  • dermatology, 115
  • dexamethasone, 155
  • diagnosis, 683
  • differentiation arrest, 216
  • diluted prothrombin time, 333
  • d-dimer, 210
  • direct antiglobulin test, 655
  • double-negative thymocytes, 216
  • Down syndrome, 576
  • doxorubicin, 155
  • drug resistance, 539, 698, 774
  • dysprothrombinaemia, 770
  • early erythroblasts, 608
  • Edinburgh, 268
  • elderly, 25
  • eluate, 655
  • epidemiology, 13
  • Epstein–Barr virus, 293
  • Epstein–Barr virus reactivation, 326
  • erythropoiesis, 608
  • erythropoietin, 608
  • essential thrombocythaemia, 244
  • Evans syndrome, 125
  • external quality assessment, 75
  • extra-medullary, 379
  • extranodal marginal zone B-cell lymphoma, 571
  • factor
  • factor concentrates, 671
  • factor VIII:C assay, 75
  • Fanconi anaemia, 630
  • Fas, 560
  • Fc receptors, 317
  • febrile neutropenia, 247
  • fetal thymic organ culture, 216
  • FLT3, 116
  • fluconazole, 656
  • fluorescence in situ hybridisation, 736
  • fluorescence in situ hybridisation panel, 705
  • fluorescence-activated cell sorting, 736
  • folate, 623
  • follicular lymphoma, 459, 743
  • Free Church of Scotland, 268
  • free light chain, 155
  • fusion gene, 286
  • gemtuzumab, 398
  • gene
  • gene expression, 640
  • gene therapy, 608
  • genetic analysis, 80
  • genetics, 630
  • globin genes, 640
  • α-globin termination mutations, 370
  • glycoprotein IIb/IIIa, 494
  • grading, 743
  • graft
  • graft failure, 36
  • graft rejection, 36
  • graft-versus-host disease, 36, 245
  • graft-versus-leukaemia effect, 56
  • graft-versus-tumour, 747
  • granulocyte colony-stimulating factor, 637
  • granulocytopenia, 658
  • growth
  • growth factor, 385
  • growth factors, 115
  • guidelines, 277, 552
  • haematological
  • haematological malignancies, 25, 478
  • haematological malignancy, 138, 656
  • haematopoiesis, 80
  • haematopoietic stem cell transplant
  • haematopoietic stem cell transplant haematopoietic stem cell transplant, 755
  • haematopoietic stem cell transplant recipients, 478
  • haematopoietic stem cell transplantation, 594
  • haemoglobin
  • haemoglobin Constant Spring, 370
  • haemoglobin Pakse, 370
  • α-haemoglobin-stabilising protein, 370
  • haemolysis, 791
  • haemolytic anaemia, 523
  • haemophilia, 13, 798, 800
  • haemophilia A and B, 671
  • haplotype, 494
  • harmonisation, 75
  • hepatic porphyria, 237
  • hepatitis C, 671
  • hereditary spherocytosis, 788, 791
  • histamine, 512
  • histone
  • histone deacetylase 1, 359
  • histone H4 acetylation, 359
  • HIV, 671
  • HLA-DR, 374
  • Hodgkin lymphoma, 115, 503
  • hypereosinophilia, 286
  • hypersplenism, 791
  • idiotype, 459
  • imaging, 410
  • imatinib, 286
  • immune response, 452
  • immunosuppression, 125
  • incompatibility, 532
  • infants, 99, 539
  • infection, 247
  • infection risk, 3
  • informed consent, 552
  • inhibitor, 66, 487, 671, 798, 800
  • integrin, 339
  • interferon gene polymorphism, 326
  • interleukin-5, 247
  • interleukin-8, 247
  • international normalised ratio, 598, 604
  • intraclonal diversity, 459
  • invasion, 469
  • invasive
  • invasive aspergillosis, 478
  • invasive fungal infections, 138
  • iron deficiency, 249
  • isochromosome, 303
  • itraconazole, 656
  • JAK2, 244, 652
  • K antigen, 374
  • K immunisation, 374
  • Langerhans
  • Langerhans cell histiocytosis, 784
  • Langerhans cells, 784
  • l-asparaginase, 740
  • latent membrane protein 1, 293
  • leucopoenia, 723
  • leukaemia, 255, 398
  • lineage, 286
  • long-term bone marrow culture, 637
  • lymphoblastic leukaemia, 615
  • lymphoma, 255
  • lymphoproliferative disorders, 3
  • mass spectrometry, 623
  • mathematical modelling, 723
  • Mcl-1, 743
  • Mediterranean stomatocytosis/macrothrombocytopenia, 660
  • methylation, 623
  • methylenetetrahydrofolate reductase, 623
  • minor histocompatibility antigens, 56
  • mixed lineage leukaemia translocation, 539
  • mobilisation, 80
  • molecular diagnosis, 653
  • monosomy 17, 230
  • morphine, 512
  • mortality, 25
  • mucosa-associated lymphoid tissue lymphoma, 571, 651
  • multiple myeloma, 114, 155, 385, 469, 584, 698
  • mutations, 630
  • myelodysplastic syndrome, 162
  • myeloma, 168, 410
  • myeloma therapy, 410
  • myelopoiesis, 637
  • myeloproliferative
  • myeloproliferative diseases, 652
  • myeloproliferative disorder, 653
  • near total splenectomy, 788
  • nephrotic syndrome, 801
  • neurological dysfunction, 523
  • neutrophils, 108, 349
  • non-ablative, 801
  • non-Hodgkin lymphoma, 42, 245
  • novel therapeutics, 698
  • nuclear factor-κB, 293
  • ocular adnexal lymphoma, 651
  • oral anticoagulation, 277
  • osteopontin, 469
  • oxidative stress, 108
  • 17p, 230
  • p210 tyrosine kinase, 359
  • P-glycoprotein, 230
  • phagocytes, 91
  • Ph-chromosome, 736
  • phosphoglycerate kinase deficiency, 523
  • phytosterol, 660
  • piceatannol, 303
  • PlA2, 494
  • plasma exchange, 204
  • platelet, 108, 339, 494, 796
  • platelet function analyser-100, 796
  • platelet function analyzer, 797
  • pneumococcal
  • pneumococcal conjugate vaccine, 788
  • pneumococcal sequential vaccination, 788
  • polyene, 658
  • polymerase chain reaction, 478
  • polymorphisms, 784
  • postsplenectomy sepsis, 791
  • pregnancy, 249
  • pregnancy outcomes, 171
  • primary
  • primary haemostasis, 796
  • primary thrombocythaemia, 530
  • progenitor cells, 774
  • prognosis, 66, 162, 705
  • prognostic factor, 560
  • prophylaxis, 3, 798, 800
  • de novo protein synthesis, 349
  • prothrombin deficiency, 770
  • PRV-1, 652
  • P-selectin, 512, 530
  • pulmonary embolism, 210
  • purging, 42
  • 9q, 303
  • quantitative polymerase chain reaction, 640
  • reactive oxygen species, 349
  • real-time quantitative reverse transcription polymerase chain reaction, 740
  • receiver operator characteristics curve, 210
  • receptor activator of nuclear factor kappa B, 503
  • red blood
  • red blood cells, 108, 655
  • reduced intensity conditioning, 747
  • refractory anaemia with excess blasts, 162
  • relapse, 594
  • renal cancer, 747
  • risk, 532
  • risk factors, 800
  • rituximab, 42
  • Rose index, 204
  • safety, 13, 532
  • screening, 3
  • second transplantation, 36
  • sensitivity, 210
  • sickle cell
  • sickle cell anaemia, 99, 512
  • sickle cell disease, 108
  • signal transduction, 293
  • signalling cascade, 385
  • small round blue cell tumours, 379
  • sodium binding, 770
  • soluble flt-3 ligand, 637
  • specificity, 210
  • splenectomy, 791
  • statistics, 794, 795
  • stem
  • stem cell transplantation, 56, 245, 410, 801, 802
  • stem cells, 80
  • survival, 469
  • Syk, 303
  • systematic review, 171, 584
  • systemic fungal infection, 656
  • targeted
  • targeted immunotherapy, 317
  • targeted therapy, 539
  • T-cell
  • T-cell acute lymphoblastic leukaemia, 216
  • T-cell epitope, 459
  • T-cell helper type 1, 452
  • T-cell response, 32
  • α-thalassaemia, 370
  • thalidomide, 155, 584
  • therapy, 398
  • thiol isomerase, 339
  • Thomas Addis, 268
  • thrombin, 197, 487, 770
  • thrombomodulin, 197
  • thrombophilia, 171, 333
  • thrombosis, 244
  • thrombotic thrombocytopenic
  • thrombotic thrombocytopenic purpura, 66
  • thrombotic thrombocytopenic purpura/haemolytic uraemic syndrome, 204
  • time-varying risk factors, 798
  • tissue factor
  • tissue factor tissue factor, 333
  • tissue factor pathway inhibitor, 333
  • TLX1/HOX11 oncogene, 216
  • Toll-like receptor, 452
  • transcription factors, 640
  • transfusion, 13, 374, 532
  • treatment, 683
  • tumour immunity, 317
  • tyrosine kinase domain mutations, 116
  • Uncaria tomentosa, 615
  • unrelated allograft, 755
  • 23-valent pneumococcal polysaccharide vaccine, 788
  • variant, 770
  • variant Creutzfeld-Jakob disease, 13
  • VH gene, 571
  • vitamin
  • vitamin B12 deficiency, 623
  • vitamin K antagonists, 277
  • vitamin K therapy, 604
  • vitamin K-dependent factors, 604
  • Waldenström macroglobulinaemia, 683
  • warfarin, 277, 598, 604
  • WHO classification, 162
  • von Willebrand factor, 530, 796